Natural history investigation will deploy latest advances to identify biomarkers, targets for early therapy A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration (AMD). By using the […]
A new procedure reported in the current issue of Nature Biotechnology has been shown to be a safe and effective method for introducing stem cells into the retina. Implantation of a specially engineered patch of retinal pigment epithelium (RPE) cells derived from stem cells has restored some vision in two people with sight loss from […]
People who cannot read their prescription labels often make medication errors, sometimes leading to hospitalization or worse. To address this serious issue, several pharmacies now provide accessible prescription labels. Provided by En-Vision America, “Scriptability” labels provide a safe and convenient way to access prescription information for individuals who cannot read standard print. The labels are […]
by Ellen Troyer, MT MA CEO & Chief Research Officer, Biosyntrx Just as hair turns gray with age, bladders weaken and memories lapse, our eyes, too, undergo a metamorphosis. Although these changes are all part of normal aging, some set the stage for more serious eye problems. As eyes age, eyelid muscles weaken, and skin becomes […]
<span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”></span><span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”></span> Learning to Live With Low Vision: One Man’s Journey Through Rehabilitation Transcript (Free distribution allowed with proper credit given) This is a dramatization of the experiences of Jim, a fictional participant in a low […]
It was reported here in November 2017 that two “anti-Ang2” drugs are being studied as potential combination therapies with established anti-VEGF treatments. RG7716 is being tested in combination with Lucentis (Genentech), and nesvacumab (REGN910) is being tested in combination with Eylea (Regeneron). Genentech has now reported that its Phase 2 BOULEVARD trials with RG7716 have […]
by Dan Roberts Advancements in lighting technology for the visually impaired have made big strides during the past 12 years. Before 2005, companies were touting their new full spectrum (“daylight”) lamps as “healthy for aging eyes”. Patients, and even their doctors, were led to believe that the sun at high noon is the best and […]
(Updated 4/17/18) Pixium Vision has announced its first successful human implantation of a wireless sub-retinal implant in a patient with atrophic dry age-related macular degeneration (AMD). So far, three patients have been implanted with the device, and results are promising. As reported here in October 2017, the implant, called PRIMA, acts like a tiny solar […]
Cases of Glaucoma, the “Sneak Thief of Sight,” Projected to Increase Significantly in Near FutureAs the population of the United States ages, the number of age-related eye disease cases is projected to grow. Glaucoma, one of the most common eye diseases, currently affects nearly 3 million people ages 40 and older, according to the Prevent […]
A global coalition of patients and representative groups concerned with vision health, aging, and avoidable blindness has launched a central hub designed to bring the most up-to-date information on the various forms of Age-related Macular Degeneration (AMD) to patients, their representatives, health care providers, and policy makers. . The Toolkit was developed by the global “GA […]